1. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004; 113:11–28.

2. Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH. Eosinophilic gastroenteritis. Medicine (Baltimore). 1970; 49:299–319.

3. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990; 31:54–58.

4. Kim NI, Jo YJ, Song HM, et al. Clinical features of eosinophilic gastroenteritis. Korean J Gastroenterol. 2004; 44:217–223.

5. Caldwell JH, Tennenbaum JI, Bronstein HA. Serum IgE in eosinophilic gastroenteritis. Response to intestinal challenge in two cases. N Engl J Med. 1975; 292:1388–1390.

6. Gonsalves N, Doerfler B, Yang G, Hirano I. A prospective clinical trial of six food elimination diet or elemental diet in the treatment of adults with eosinophilic gastroenteritis. Gastroenterology. 2009; 136(suppl):A280.

7. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol. 1999; 103:717–728.

8. Lee CM, Changchien CS, Chen PC, et al. Eosinophilic gastroenteritis: 10 years experience. Am J Gastroenterol. 1993; 88:70–74.

9. Jeon EJ, Lee KM, Jung DY, et al. Clinical characteristics of 17 cases of eosinophilic gastroenteritis. Korean J Gastroenterol. 2010; 55:361–367.

10. Kelly KJ. Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr. 2000; 30(suppl):S28–S35.

11. Walker NI, Croese J, Clouston AD, Parry M, Loukas A, Prociv P. Eosinophilic enteritis in northeastern Australia. Pathology, association with Ancylostoma caninum, and im-plications. Am J Surg Pathol. 1995; 19:328–337.

12. Van Dellen RG, Lewis JC. Oral administration of cromolyn in a patient with protein-losing enteropathy, food allergy, and eosinophilic gastroenteritis. Mayo Clin Proc. 1994; 69:441–444.

13. Bolukbas FF, Bolukbas C, Uzunkoy A, Baba F, Horoz M, Ozturk E. A dramatic response to ketotifen in a case of eosinophilic gastroenteritis mimicking abdominal emergency. Dig Dis Sci. 2004; 49:1782–1785.

14. Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci. 2001; 46:1787–1790.

15. Foroughi S, Foster B, Kim N, et al. Anti-IgE treatment of eo-sinophil-associated gastrointestinal disorders. J Allergy Clin Immunol. 2007; 120:594–601.